Ashland Inc. Reports Preliminary Financial Results for Third Quarter 2015
Press Release
Ashland Inc. Reports Preliminary Financial Results for Third Quarter 2015
- Earnings from continuing operations total
$1.68 per diluted share - Adjusted earnings from continuing operations grow 17 percent, to
$1.91 per diluted share - Adjusted EBITDA equals
$290 million ; EBITDA margin rises 260 basis points to 21.2 percent - Company completes previous
$1.35 billion share repurchase authorization
Quarterly Highlights
(in millions except per-share amounts) | Quarter Ended | |||||
2015 | 2014 | |||||
Operating income | $ | 196 | $ | 143 | ||
Key items* | 11 | 69 | ||||
Adjusted operating income* | $ | 207 | $ | 212 | ||
Adjusted EBITDA* | $ | 290 | $ | 298 | ||
Diluted earnings per share (EPS) | ||||||
From net income | $ | 1.56 | $ | 1.25 | ||
From continuing operations | $ | 1.68 | $ | 0.90 | ||
Key items* | 0.23 | 0.73 | ||||
Adjusted EPS from continuing operations* | $ | 1.91 | $ | 1.63 | ||
Cash flows provided (used) by operating activities from continuing operations | $ | (255) | $ | 211 | ||
Free cash flow* | 184 | 155 | ||||
* See Tables 5, 6 and 7 for Ashland definitions and U.S. GAAP reconciliations. |
Ashland reported earnings from continuing operations of
For the remainder of this news release, financial results have been adjusted to exclude the effect of key items
in both the current and prior-year quarters. On this basis, Ashland's adjusted income from continuing operations in the third quarter of fiscal 2015 was
Ashland's results as compared to the year-ago quarter were as follows:
- Sales were negatively affected by macroeconomic factors including foreign exchange rates and reduced demand in the North American energy market. In addition, Ashland's strategic decision to divest non-core product lines also negatively affected sales. These factors reduced sales by a total of approximately
$200 million ; - As a result of the recent global restructuring and foreign exchange rates, selling, general and administrative (SG&A) costs declined 9 percent, to
$231 million when adjusted for key items; and - Adjusted EBITDA margin rose by 260 basis points, to 21.2 percent. This strong EBITDA margin improvement was driven by an increasingly differentiated product mix, combined with disciplined cost control.
"While a number of factors have affected our top-line results, the Ashland team executed at a high level in the third quarter to drive strong earnings and margin growth," said
He added: "At the same time, Ashland's global teams have succeeded in taking out costs across the organization as part of a broader plan to improve our competitive position. We are now focused on sustaining those cost reductions and improvements. These efforts, together with our focus on generating improved business and product mix, led to a significant increase in EBITDA margin. We remain committed to achieving Ashland's near- and mid-term EBITDA margin targets."
He also said Ashland has prioritized the effective allocation of capital through targeted investments to support its core product lines and share repurchases. Among the recent targeted investments were capacity expansions for hydroxyethylcellulose (HEC) production. In addition, the company recently announced an agreement to acquire AkzoNobel's Zeta Fraction* technology, which will strengthen Ashland's position in personal care while continuing its expansion into sustainable, natural-based specialty ingredients. Ashland also continued to return cash to shareholders through the recently completed
"We believe Ashland stock is undervalued and we see share buybacks as an attractive capital allocation opportunity," Wulfsohn said.
Reportable Segment Performance
To aid understanding of Ashland's ongoing business performance, the results of Ashland's reportable segments are described below on an adjusted basis and EBITDA, or adjusted EBITDA, is reconciled to operating income in Table 7 of this news release.
Specialty Ingredients reported its fifth consecutive quarter of year-over-year EBITDA margin improvement, driven by better business and product mix, good cost control and positive price over cost. EBITDA
margin increased 200 basis points to 23.7 percent. Good cost management led to lower SG&A expenses, excluding the impact of foreign exchange, which totaled
The Consumer Specialties division continued to perform well on higher demand for Ashland's unique, higher-value-added product lines as sales grew a currency-adjusted 2 percent. Pharmaceuticals led the way with currency-adjusted sales growth of 5 percent. Personal-care sales grew 4 percent, after currency adjustment, on continued strength in oral- and hair-care applications. These results were offset by a currency-adjusted 13 percent decline in Industrial Specialties, due largely to continued weakness in the energy and construction markets. Ashland has taken steps
to mitigate the reduced demand for energy-related products by suspending a portion of its manufacturing capacity. Ashland is seeing good growth for coatings-related products as a result of recent manufacturing capacity increases. The company is supporting that growth through the ongoing expansion at its manufacturing plant in
Looking ahead to the fiscal fourth quarter, Specialty Ingredients expects continued growth in the high-value-add, higher-margin areas of the business. However, the business unit expects to face headwinds from currency, continued weakness in energy
markets and exited product lines. Specialty Ingredients expects fourth-quarter sales to be in the range of
Within Performance Materials, composites posted strong year-over-year margin growth from improved product mix and solid pricing discipline. As previously disclosed, Performance Materials completed both a planned turnaround and an unplanned shutdown at its two intermediates and solvents (I&S) plants during the quarter. The estimated impact from these temporary closures was approximately
For the fourth quarter, Performance Materials expects overall results to decline sequentially, in line with normal seasonality. The business unit expects another quarter of solid performance within composites to be offset by continued
pricing weakness within I&S. As a result, Performance Materials expects sales to be in the range of
Valvoline reported record quarterly earnings driven by continued improvement in product mix, strong same-store sales growth at VIOC and good overall volume growth. EBITDA rose 17 percent, to
For the fourth quarter, Valvoline expects continued strong performances across each channel. Sales are expected to decline sequentially by 5-7 percent, to approximately
Ashland's effective tax rate for the
Outlook
Looking ahead, Wulfsohn said he expects Ashland to sustain its disciplined approach to capital allocation. In addition to returning cash to shareholders, the company will continue making targeted investments in higher-margin, highly differentiated core product lines that add value for customers. He also sees opportunities to strengthen the company's market leadership through product innovation, commercial excellence, and world-class operations.
"Ashland is fortunate to have two outstanding business platforms with attractive growth opportunities and experienced leadership teams. Since early this year, both our Chemicals Group and Valvoline have been developing their respective strategic plans to drive profitable growth and take the actions required to maximize shareholder value. A great deal of time and effort has been invested by our global business teams to better understand our markets, our customers and the opportunities where we can deliver the most value to Ashland's stakeholders. We expect to finalize this work in the current quarter, in conjunction with the completion of Ashland's fiscal 2016 strategic plan. We look forward to sharing more information with investors later this year," Wulfsohn said.
Ashland today announced plans to host an Investor Day on
Conference Call Webcast
Ashland will host a live webcast of its third-quarter conference call with securities analysts at
Use of Non-GAAP Measures
This news release includes
certain non-GAAP (Generally Accepted Accounting Principles) measures. Such measurements are not prepared in accordance with GAAP and should not be construed as an alternative to reported results determined in accordance with GAAP. Management believes the use of such non-GAAP measures assists investors in understanding the ongoing operating performance of the company and its segments. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP amounts have been reconciled with reported GAAP results in Tables 5, 6 and 7 of the financial statements provided with this news release.
About Ashland
- 0 -
C-ASH
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as "anticipates," "believes," "expects," "estimates," "is likely," "predicts," "projects," "forecasts," "may," "will," "should" and "intends" and the negative of these words or other comparable terminology. In addition, Ashland may from time to time make forward-looking statements in its annual report, quarterly reports and other filings with the
(1) Preliminary Results
Financial results are preliminary until Ashland's Form 10-Q is filed with the
SM Service mark, Ashland or its subsidiaries, registered in various countries.
(TM) Trademark, Ashland or its subsidiaries, registered in various countries.
*Trademark owned by AkzoNobel
FOR FURTHER INFORMATION:
Investor Relations:
Jason Thompson
+1 (859) 815-3527
jlthompson@ashland.com
Media Relations:
Gary Rhodes
+1 (859) 815-3047
glrhodes@ashland.com
Q3 2015 Earnings Release & Financial Tables
Q3 2015 Earnings Prepared Remarks
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source:
News Provided by Acquire Media